(CNN) – Ivermectin, a drug that is normally used to treat parasites, including smallpox and rabies, does not have a significant impact on improving the symptoms of patients with covid-19, according to a new study published in the journal Journal of the American Medical Association (JAMA).
In addition, the Health Care Panel of Health Institutions provides that it does not have sufficient data to recommend the use of the drug to treat patients with covid-19.
MIRA: Why did the prescriptions for ivermectin for covid-19 not work for you? El Dr. Explicit Huerta
Including studies that demonstrate that it works, some medicines have promoted the drug. It is a drug that has been treated with anti-inflammatory and anti-inflammatory properties to prevent the virus from replicating in laboratory studies. But the hecho of what works in the laboratory does not mean that it works in real life. The Mayor of Conventional Medicine has reserved its juice with respect.
This studio is designed to evaluate ivermectina in Colombia
In this study center located in Cali, Colombia, there are 500 adults with a liver disease who are presenting during 7 days of volunteering to help them try the medicine. The assay is what is known as a double key control assay assay, the standard of the assays of gold.
The meeting of the volunteers received the medicine during five days, the other meeting received a placebo and attention was paid. Patients will be enrolled in the enrollment between July 2020 and November 2020 and physicians will perform a follow-up by December.
At the end of the session, I have a random number of adverts (mainly cabeza dollars) in both groups of volunteers. Patients who receive the medicine they take will reduce their symptoms in 10 days. For the group that received the placebo, there were 12 days. These days do not consider a “significant” major.
“The hallazgos do not support the use of ivermectin for the treatment of covid-19 lev”, concludes the study. In addition, it may be necessary to increase the size of the ivermectin proportion to some type of benefit to patients with covid-19. In this case, the study is centered on the syntheses and the living life.